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Coxsackieviral infections have been linked etiologically to multiple diseases. The serotype CB4 is associated with acute
pancreatitis and autoimmune type 1 diabetes. To delineate the mechanisms of host survival after an acute infection with CB4
(strain E2), we have investigated the role of nitric oxide (NO), generated by the inducible form of nitric oxide synthase (NOS2),
in viral clearance and pancreatic b-cell maintenance. Mice deficient in NOS2 (NOS22/2 mice) and their wild-type (wt)
counterparts were injected with CB4, after which both groups developed severe pancreatitis, hepatitis, and hypoglycemia
within 3 days. Within 4 to 7 days postinfection (p.i.), most of the NOS22/2 mice died and at a strikingly higher mortality rate
than wt mice. Histological examination of pancreata from both infected NOS22/2 and infected wt mice revealed early and
complete destruction of the pancreatic acinar tissue, but intact, insulin-stained islets. When examined up to 8 weeks p.i.,
neither surviving NOS22/2 mice nor surviving wt mice developed hyperglycemia. However, the clearance of infectious CB4
was different between the mice. The spleens of NOS22/2 survivors were cleared of infectious virus with kinetics similar to
that of wt mice, but the livers, pancreata, kidneys, and hearts of the NOS22/2 groups cleared virus more slowly than those
of the wt group. This delayed clearance was particularly prominent in the livers of infected NOS22/2 mice, which also showed
prolonged histopathological features of viral hepatitis. Taken together, this outcome suggests that NOS2 (and NO) is not
required for the prevention of pancreatic b-cell depletion after CB4 infection. Instead the critical actions of NOS2 apparently
occur early in the host immune response, allowing mice to survive and clear virus. Moreover, the data support the existence
of an organ-specific dependency on NO for a rapid clearance of CB4. © 2001 Academic Press
Key Words: pancreatic b-cell; coxsackievirus; insulin-dependent diabetes mellitus; hepatitis; insulin; nitric oxide; nitric oxide
synthase; NOS2; pancreatitis.
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Coxsackieviruses are small, single-stranded RNA vi-
ruses belonging to the enteroviral group of picornavi-
ruses (Chapman et al., 1997; Melnick, 1985; Rueckert,
1985). Although most human coxsackieviral infections
are asymptomatic or show minor clinical manifestations,
cases of coxsackievirus-induced pancreatitis, myocardi-
tis, aseptic meningitis, and hepatitis have been reported
(Melnick, 1985). Coxsackieviruses have also been pro-
posed as etiological agents of idiopathic hepatitis
(O’Shaughnessey and Beucher, 1962) and pancreatitis
(Ramsingh, 1997). In addition, seroepidemiological data
from human studies and experiments in animals have
indicated that coxsackievirus infections may contribute
to the initiation or acceleration of autoimmune (type 1)
insulin-dependent diabetes mellitus (reviewed in Graves
et al., 1997; Hyoty et al., 1998; Knip and Åkerblom, 1999;
Ramsingh et al., 1997; Szopa et al., 1993). Indeed, assum-
ing that autoimmune destruction of pancreatic b-cells
1 This is Manuscript 13252-IMM from The Scripps Research Institute.
2 To whom correspondence and reprint requests should be ad-
dressed at Department of Immunology (IMM-23), The Scripps Research
Institute, 10 550 N. Torrey Pines Road, La Jolla, CA 92037. Fax: (858) 784
9096. E-mail: noras@scripps.edu.
205esults from multiple events, coxsackieviral infection may
e the final trigger for the disease to ensue (Ramsingh et
l., 1997).
Infections with the coxsackievirus serotype B4 (CB4)
ave been etiologically linked to type 1 diabetes in hu-
ans, and CB4 was isolated from patients who died
hortly after being diagnosed with the disease (Szopa et
l., 1993). Several CB4 isolates can infect human and
urine pancreatic b-cells and cause cellular dysfunction
and/or death in vitro (Frisk et al., 1994; Roivainen et al.,
2000; Szopa et al., 1986, 1990; Yoon et al., 1979). More-
over, some clinical isolates, after several passages
through mouse pancreatic b-cell cultures, fulfilled Koch’s
ostulate by inducing a diabetes-like syndrome in sus-
eptible strains of mice (Toniolo et al., 1982; Yoon et al.,
978). Although some of those mice developed hypergly-
emia, additional studies showed that systemic infection
ith CB4 rarely resulted in a complete loss of pancreatic
b-cells (Horwitz et al., 1998, 1999; Ramsingh et al., 1989;
ee and Tilles, 1995; Szopa et al., 1989). Indeed, CB4
ailed to cause or accelerate type 1 diabetes even in the
OD mouse, which is genetically predisposed to de-
elop the disease (Horwitz et al., 1998). Why the infection
f pancreatic b-cells should have such disastrous con-
sequences in vitro but not in vivo is unknown. However,
some antiviral defense mechanism mounted by the in-
0042-6822/01 $35.00
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206 FLODSTRO¨M ET AL.fected host or b-cells themselves may contribute to
b-cell survival in vivo.
So far little is known about the mechanisms respon-
sible for viral clearance and host survival during infection
with CB4. Characterization of these events could, how-
ever, contribute to the understanding of the mecha-
nism(s) by which CB4 infection may precipitate the de-
velopment of type 1 diabetes. Animals inoculated with
CB4 will develop a severe pancreatitis resulting in an
inflammatory destruction of the exocrine pancreas
(Lansdown, 1976). In the acute stage of infection the
mice become hypoglycemic, most likely due to the mas-
sive degeneration of the exocrine acinar cells. Depend-
ing on viral dose and the susceptibility of the mouse
strain used (Ramsingh et al., 1989; Webb et al., 1976), the
infected mice either die within 4–21 days postinfection
(p.i.) or clear the viral infection and survive. Only a few
mouse strains (i.e., SJL and CD-1) demonstrate signs of
pancreatic b-cell dysfunction by developing hyperglyce-
ia and/or impaired glucose tolerance (reviewed in
amsingh et al., 1997). Using this experimental system,
rogress has been made in identifying components of
he immune system which can contribute to viral clear-
nce and survival, but also to immunopathology (Horwitz
t al., 1999; Ramsingh et al., 1999; Vella and Festenstein,
992).
In the early 1990s, the gas nitric oxide (NO) was shown
o mediate one of the antiviral effects induced by inter-
erons (type I and II) (Karupiah et al., 1993). NO is a small
adical involved in the regulation of numerous biological
unctions including vascular tone and neurotransmission
Forstermann et al., 1995; Kro¨nke et al., 1997). NO is also
an immunoregulator (Kolb and Kolb-Bachofen, 1999) and
a key factor in immunological killing of invading patho-
gens (Bogdan et al., 2000; Miller and Britigan, 1997; Reiss
and Komatsu, 1998). NO is generated in a reaction cat-
alyzed by one of the three isoforms of the enzyme, nitric
oxide synthase (NOS) (Stuehr, 1999). The neuronal
(nNOS or NOS1) and endothelial (eNOS or NOS3) iso-
forms are responsible for production of the small
amounts of NO required for physiological functions. The
third isoform, the inducible NOS (iNOS or NOS2), syn-
thesizes large amounts of NO that, among other things,
contribute to the host defense against invading microor-
ganisms.
Normally, NOS2 is not expressed but can be induced
in many cell types by immunological stimuli such as
proinflammatory cytokines, double-stranded RNA
(dsRNA) and bacterial lipopolysaccharide (Forstermann
et al., 1995; Kro¨nke et al., 1997). Pancreatic b-cells ex-
press NOS2 and produce large amounts of NO in re-
sponse to cytokines and dsRNA in vitro (Eizirik et al.,
1996; Heitmeyer et al., 1999). Theoretically, then, NOS2
could be part of a cytokine-induced antiviral defense
response, protecting b-cells during viral infections
(Eizirik and Leijerstam, 1994).Expression of NOS2 is also known to be upregulated vduring viral infections, including those with members of
the picornaviridae family (Reiss and Komatsu, 1998). Our
group has found NOS2 expressed in the pancreata of
NOD mice infected with CB4 (Horwitz et al., 1999). In this
previous study, the administration of aminoguanidine, an
inhibitor of NOS2, did not significantly alter the survival
rates of infected mice and failed to affect the kinetics of
viral clearance. However, in a number of other disease
models in which the role of NOS2 has been evaluated,
the use of NOS2 inhibitors has given inconsistent results
(reviewed in Eizirik et al., 1996; Reiss and Komastu, 1998;
Kelly and Gold, 1999). There may be several explanations
of the varying results, one being that none of the NOS2
blockers is absolutely selective for the NOS2 isoform
(Moncada et al., 1997). Thus, one blocker may also in-
eract with the other NOS isoforms (NOS1 and NOS2)
nd other enzymes outside the NOS family. In the case of
he aminoguanidine it has been observed that, in addi-
ion to inhibiting NOS2, the compound will also block the
ctivities of the enzyme diamine oxidase (DAO). Inacti-
ation of DAO has been shown to cause serious respi-
atory and vascular side effects (reviewed in Nilsson,
999). Thus, the nonspecific effects of NOS2 inhibitors
ay give rise to changes in biological activities other
han those regulated by NOS2. It is likely that these
nwanted side effects will make it difficult to draw clear
onclusions when the inhibitors are being used in bio-
ogical systems.
Because the function of NOS2 during an infection with
B4 is uncertain, we have in the present study used mice
enetically deficient in NOS2 to evaluate the importance
f NOS2-derived NO for (i) host survival, (ii) clearance of
nfectious virus, and (iii) pancreatic b-cell maintenance,
after an acute infection with CB4.
RESULTS
NOS2 is expressed in the pancreata of wild-type mice
infected with CB4
To trace NOS2 expression, each of 13 wild-type (wt)
and 14 NOS22/2 mice was inoculated ip with 102 PFU of
B4 and then sacrificed on day 4 or 7 pi. As expected,
ccording to immunohistological analysis, no NOS2 was
etectable in formalin-fixed pancreata of uninfected wt
ice (Fig. 1A; n 5 3) or NOS22/2 mice (n 5 3; data not
hown), nor in NOS22/2 mice infected with CB4 (n 5 3;
not shown). Nevertheless, NOS2 was clearly expressed
in the pancreata of infected wt mice on day 4 (n 5 4; not
shown) and day 7 p.i. (Fig. 1B; n 5 13). NOS2-expressing
ells appeared to be confined to mononuclear infiltrates
n the exocrine part of the pancreas, whereas NOS2-
ositive cells were rarely seen in pancreatic islets.
ecreased survival of NOS22/2 mice infected
ith CB4
The majority of wt mice receiving 102 PFU CB4 sur-
ived for the initial observation period of 28 days (Fig.
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207CB4 INFECTION IN NOS22/2 MICE2A). In contrast, early fatalities followed infection of
NOS22/2 mice, most (70%) of which died 4–7 days p.i.
P , 0.01; NOS22/2 mice vs wt mice, x2 test). Only at a
igher viral dose (104 PFU) did the wt mice show a
ortality rate similar to that of infected NOS22/2 mice
(percentage of mice not surviving during a 28-day obser-
vation period; NOS22/2, 87.5% (14/16); wt, 62.5% (10/16);
s). Mice inoculated with the lower dose (102 PFU) and
surviving beyond the 28th day p.i. stayed alive for at least
8 weeks, at which time the experiment was terminated
(not shown). To confirm that the increased susceptibility
stemmed from inactivation of the NOS2 gene, not strain
polymorphism, the parental inbred strains C57BL/6 and
129SvEv, were infected with 102 PFU CB4 (Fig. 2B). By
ay 28 p.i., 77% (8/12) of the infected C57BL/6 mice and
FIG. 1. NOS2 is expressed in the pancreata of mice infected with CB4
later. Paraffin sections of formalin-fixed pancreata from (A) uninfected
uninfected mice did not contain NOS2-expressing cells, but in pancreat
sections shown are representative of pancreata from 3 to 13 uninfecte3% (10/12) of the 129SvEv mice were still alive.OS2 is not required for the maintenance of
ancreatic b-cells during an acute in vivo infection
ith CB4
Infected NOS22/2 mice showed an initial decrease
in blood glucose (BG) levels, similar to that observed
in wt mice. Preceding infection, BG levels in wt and
NOS22/2 mice were 130 6 12 (n 5 5) and 140 6 13
mg/dl (n 5 5), respectively. Three days p.i., the BG
levels in wt mice had decreased to 73 6 5 mg/dl (n 5
5) and in NOS22/2 mice to 83 6 7 mg/dl (n 5 5). All wt
nd surviving NOS22/2 mice continued to display sub-
normal BG levels even after the acute stage of infec-
tion. However, no hyperglycemia was observed in any
of the infected wt (n 5 6) or NOS22/2 (n 5 7) mice for
ype mice were injected ip with 102 PFU CB4 and then sacrificed 7 days
B) infected mice were stained with an NOS2 antibody. Pancreata of
ected mice several cells in the exocrine parts were NOS2 positive. The
infected animals. Original magnification 3400.. Wild-t
and (
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208 FLODSTRO¨M ET AL.b-cells were maintaining their abilities to synthesize
nd release insulin. At 8 weeks p.i., the BG levels in wt
nd NOS22/2 mice were 81 6 5.1 (n 5 6) and 100 6 3.5
mg/dl (n 5 6), respectively.
At 3 and 4 days p.i., histological evaluation of pan-
creata from uninfected NOS22/2 mice (Fig. 3A) and wt
mice (not shown) compared to infected wt and
NOS22/2 mice revealed mononuclear infiltrates in the
exocrine tissues and acinar cells undergoing necrosis
(NOS22/2 mice, Fig. 3B; wt mice, not shown). In both wt
2/2
FIG. 2. Mice deficient in NOS2 have an increased mortality rate a
57BL/6J (n 5 12) and 129SvEv mice (n 5 12) were injected ip with
t mice, x2 test.and NOS2 mice, the pancreatic islets appeared Nintact and without mononuclear infiltrates. Pancreata
of infected mice sacrificed at 8 weeks p.i. showed a
complete absence of acinar cells and some replace-
ment of the lost exocrine tissue by fatty tissue
(NOS22/2 mice, Fig. 3C; wt mice, not shown). Again, no
istopathological differences were obvious in the pan-
reata of infected wt mice compared to (surviving)
OS22/2 mice. Immunohistochemical staining with an
nsulin antibody indicated no significant reduction in
he number of insulin-positive b-cells in either wt or
2/2
ection with CB4. (A) Wt (n 5 13) and NOS22/2 (n 5 24) mice or (B)
U CB4 (E2) and then monitored for 28 days. *P , 0.01; NOS22/2 vsfter inf
102 PFOS2 mice, at any time during the 8-week study
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209CB4 INFECTION IN NOS22/2 MICEperiod (NOS22/2 mice, Figs. 3B and 3C; wt mice, not
shown).
NOS2 contributes to a rapid clearance of infectious
virus during acute infection with CB4
Previous studies of several inbred mouse strains have
established the peak of CB4 replication at day 3 p.i.
(Loria et al., 1984; Vella and Festenstein, 1992). Similarly,
n day 3 p.i., we measured high concentrations of virus
n the pancreata, livers, spleens, kidneys, and hearts of
he infected mice, with no significant differences be-
ween wt and NOS22/2 mice (Table 1). Nevertheless,
from day 4 p.i., when the first infected NOS22/2 mice died
Fig. 2), differences in viral loads were detected (Table 1).
pecifically, viral titers in livers of wt mice were already
ecreasing, whereas those of NOS22/2 mice continued
o increase, indicating a delay in the peak of viral repli-
ation in this organ. On day 5 p.i., viral titers in all organs
ut the hearts of infected NOS22/2 mice were lower than
on day 4 p.i. Nevertheless, on day 7 p.i., significantly
more infectious virus could be measured in the pan-
creas, liver, and kidneys of the infected NOS22/2 mice
han in wt mice. Interestingly, although control of viral
eplication was altered in most organs of the infected
OS22/2 mice, infectious virus was cleared from the
spleens with kinetics similar to that of wt mice. After 10
days, viral titers in liver and kidneys from infected wt
mice were below the detection level of our assay (10
PFU/g tissue). Virus could still be measured in the pan-
creas, spleen, and heart of infected wt mice and in all
organs of most of the infected NOS22/2 mice. At 14 days
2/2
T
Delayed Clearance of Infectious Virus in
Organ Strain 3 4
Pancreas NOS22/2 11.0 6 0.5 (5) 11.2 6 0.4 (3) 10.9
NOS21/1 10.4 6 0.3 (5) 11.3 6 0.3 (6) 10.3
pleen NOS22/2 8.6 6 0.2 (5) 8.3 6 0.2 (3) 8.0
NOS21/1 8.6 6 0.1 (5) 8.4 6 0.1 (6) 7.8
Liver NOS22/2 9.1 6 0.5 (5) 9.9 6 0.1 (3)** 7.2
NOS21/1 9.4 6 0.4 (5) 8.7 6 0.2 (6) 7.0
Kidney NOS22/2 7.8 6 0.1 (5) 7.5 6 0.1 (3)* 6.8
NOS21/1 8.0 6 0.2 (5) 7.1 6 0.4 (6) 6.4
Heart NOS22/2 8.2 6 0.2 (5) 7.1 6 0.4 (3) 8.0
NOS21/1 8.2 6 0.1 (5) 7.6 6 0.3 (6) 7.6
Note. Wild-type (NOS21/1) and NOS22/2 mice were injected ip with 10
were harvested and assessed for infectious virus content by plaque a
log10(PFU/g tissue), are means 6 SEM of the titers measured in organs
ays 4 and 5 onward reflect only a subpopulation of the infected NOS2
this time point (see Fig. 2). The detection limit of the assay was 10 PF
a On day 10 p.i. the liver of one of the infected NOS22/2 mice had a
virus could be detected in the livers of the other 3 infected NOS22/2 m
* P , 0.05, **P , 0.01, and ***P , 0.001: infected NOS22/2 animals.i., viral titers in the organs from both wt and NOS2 emice were below the detection level, with the exception
of the hearts, which in both NOS22/2 and wt mice were
leared by day 21 p.i.
he delayed clearance of infectious CB4 in NOS22/2
mice parallels delayed remission of acute hepatitis in
NOS22/2 mice
Figures 4A and 4B show formalin-fixed livers from
ninfected wt and NOS22/2 mice, respectively. By days 3
and 4 p.i., livers of the two mouse strains looked similar
(Figs. 4C and 4D), both typical of ongoing acute viral
hepatitis with hepatocytes undergoing ballooning degen-
eration or showing features of apoptotic cell death (nu-
clear chromatin condensation and fragmentation). Minor
mononuclear infiltration surrounded sinusoids, and mi-
totic figures indicated regenerating hepatocytes.
By day 7 p.i., the viral hepatitis had resolved in infected
wt mice (Fig. 4E). No fibrosis was noted upon Massons
trichrome staining of formalin-fixed liver sections (not
shown). However, at day 7 p.i., all livers of infected
NOS22/2 mice showed clear evidence of ongoing hepa-
itis (Fig. 4F) visible as massive ballooning degeneration
f hepatocytes in the majority of the periportal lobules
ith some spreading into nearby areas. Only a few
epatocytes showed condensed and marginated nuclear
hromatin. Mononuclear cell infiltration was extensive,
nd occasional clusters of polymorphonuclear cells
ould be observed throughout the parenchyma.
By day 14 p.i. the livers of both mouse strains ap-
eared similar, and recovery from viral infections was
2/2
/2 Mice during Acute Infection with CB4
Day postinfection
7 10 14 21
4) 10.9 6 0.3 (4)* 4.2 6 1.9 (4) ,1 (3) ND
3) 8.2 6 1.0 (4) 1.7 6 1.7 (2) ,1 (3) ND
4) 5.4 6 0.2 (4) 2.2 6 1.4 (4) ,1 (3) ND
3) 4.8 6 0.4 (4) 1.6 6 1.6 (2) ,1 (3) ND
4) 5.2 6 0.2 (4)*** 0.9 6 0.9 (4)a ,1 (3) ND
3) ,1 (4) ,1 (2) ,1 (3) ND
4) 5.4 6 0.3 (4)* 1.3 6 1.3 (4) ,1 (3) ND
3) 2.7 6 1.0 (4) ,1 (2) ,1 (3) ND
4) 7.7 6 0.5 (4) 7.1 6 1.2 (4) 3.4 6 1.0 (3) ,1 (4)
3) 5.0 6 1.8 (4) 4.9 6 1.2 (2) 2.0 6 0.2 (3) ,1 (3)
B4 and then sacrificed at days 3, 4, 5, 7, 10, 14, and 21 p.i. Their organs
s described under Materials and Methods. The results, presented as
6 animals for each time point and genotype. Note that the results from
e since the majority of infected NOS22/2 mice did not survive beyond
sue. ND, not determined.
er of 3.6 log10(PFU/g tissue), whereas at this time point no replicating
cted wt animals (Student’s unpaired t test).ABLE 1
NOS22
5
6 0.2 (
6 0.2 (
6 0.1 (
6 1.0 (
6 0.2 (
6 1.1 (
6 0.1 (
6 0.8 (
6 0.3 (
6 0.4 (
2 PFU C
ssay a
from 2–
2/2 mic
U/g tis
viral tit
ice.vident (NOS2 , Fig. 4G; wt, not shown). Histological
FIG. 3. Pancreatic b-cells are preserved in NOS22/2 mice infected with CB4. NOS22/2 mice infected with 102 PFU CB4 were sacrificed at day 4 or
week 8 p.i. Paraffin sections of formalin-fixed pancreata from (A) uninfected and infected mice at (B) 4 days p.i. or (C) 8 weeks p.i. were stained with
an antibody to insulin. The sections shown represent pancreata from 3 to 6 infected and control animals, all with intact islets and insulin-positive
b-cells. Identical staining of pancreata from infected wt mice also identified intact, insulin-positive islets (not shown). Original magnification 3400.
211CB4 INFECTION IN NOS22/2 MICEFIG. 4. Histopathological features of CB4-induced acute hepatitis in infected NOS22/2 and wt mice. Wt and NOS2/2 mice were infected with 102
PFU CB4 and sacrificed on days 4, 7, or 14 p.i. Formalin-fixed livers were stained with hematoxylin and eosin. (A) Liver from an uninfected wt mouse
2/2 2/2and (B) from an uninfected NOS2 mouse. (C and D) Day 4 p.i. (C) Liver from a wt mouse and (D) liver from an NOS2 mouse with acute hepatitis
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212 FLODSTRO¨M ET AL.analysis revealed no fibrosis or fibrotic lesions as late as
8 weeks p.i. (not shown).
DISCUSSION
The present study evaluated whether NO, produced by
NOS2, could be involved in a host’s immune response to
CB4 viral infection and/or in the prevention of virally
instigated type 1 diabetes. Our findings establish, for the
first time, that the radical NO is an important factor for
host survival and clearance of infectious virus during an
acute infection with CB4. Moreover, several organs, par-
ticularly the liver, depend on NOS2 for a rapid viral
clearance.
Upregulation of NOS2 appears to be a common event
during infections with either RNA or DNA viruses (Reiss
and Komatsu, 1998). In this study, we found NOS2 ex-
pressed in mice infected with CB4. NOS2 was also
expressed during infection by other viruses of the picor-
naviridae family, such as CB3, encephalomyocarditis vi-
rus, and Theiler’s murine encephalomyelitis virus (Reiss
and Komatsu, 1998). Since early reports that NO is an
important mediator of interferon-g-induced inhibition of
iral replication (Karupiah et al., 1993), it has become
evident that NO produced by a host’s immune response
against a viral infection can also contribute to a harmful
aftermath (Karupiah et al., 1998). Thus, NOS2 expression
and NO production can be either beneficial or detrimen-
tal during a viral infection. Our present studies indicate
that NOS2 expressed during an infection with CB4 does
not significantly contribute to the CB4-induced tissue
damage. Instead, the heightened susceptibility of these
NOS2-deficient mice to infection with CB4 denotes that
NOS2 is crucial for host survival.
The early death of infected NOS22/2 mice presages
the importance of NOS2 (and NO) during the first stages
of CB4 infection. Clearly, a functional innate immune
response is imperative for the development of a second-
ary, specific response to invading pathogens (Bogdan et
al., 2000). The innate response then, albeit without any
particular specificity, holds infection in check, allowing
time for T- and B-cell responses to develop and become
effective. Previous studies of coxsackieviruses and other
enteroviruses have pointed out components of the early,
innate immune response (IFN-g, macrophages, and NK
ells), as well as the late, acquired immune system (T-
nd B-cells, antibodies), as being important for viral
learance and host survival during different stages of
nfection (Chow et al., 1992; Godeny and Gauntt, 1987;
orwitz et al., 1999; Leipner et al., 1999; Mena et al.,
visible as some mononuclear infiltration and hepatocytes undergoing a
NOS22/2 mouse. At this time point, livers from infected wt mice had
howed an ongoing hepatitis with hepatocytes in the periportal region
14 days p.i. with normohistological features indicating recovery from v
control animals per time point. Original magnification 3400.999; Ramsingh et al., 1999; Vella and Festenstein, 1992).
ince NO is a recognized key factor in the antimicrobial
ctivities of the innate immune system (Bogdan et al.,
000; MacMicking et al., 1997), NO may restrict CB4
eplication early during infection, allowing enough time
or specific immune responses to differentiate and be-
ome activated. Indeed, although similar levels of infec-
ious virus were found in infected NOS22/2 and wt mice
on day 3 p.i., viral titers were still rising in livers of the
NOS22/2 mice on day 4 p.i. The first deaths of infected
NOS22/2 mice at that time suggest that the failure to
nhibit viral replication before adaptive responses de-
elop perpetuated their virally induced death. Addition-
lly, the survival of infected NOS22/2 mouse during the
initial 4 to 7 days after encountering the virus (approxi-
mately 35% of infected NOS22/2 animals in the present
tudy) evidently enabled them to clear viruses from their
rgans and survive. The possibility that these mice sur-
ived long enough for T- and B-cell responses to mature
upports the importance of NOS2 at an early stage of
nfection.
In striking contrast to the profound delay in viral clear-
nce of the liver and higher titers of virus by day 7 in the
ancreas and kidneys, the spleens of infected NOS22/2
mice cleared with timing similar to that of the spleens of
wt mice. This phenomenon, which to our knowledge has
not previously been described for coxsackieviral infec-
tions, predicts that certain organs depend more than
others do on NO in restraining CB4 replication. Mice
infected with murine cytomegalovirus (mCMV) show a
similar response (Orange et al., 1995; Tay and Welsh,
1997). In that system, the host relies on NK cells for the
initial suppression of viral replication. Yet, NK cells seem
to use different strategies in livers than in spleens to fight
mCMV infection. In the latter organ, the actions of NK
cells are dependent on perforin, whereas the production
of IFN-g is indispensable for the effects of NK cells in the
iver. In turn, IFN-g is necessary for the induction of
NOS2 expression in the infected liver, and NO executes
the suppression of viral replication. NK cells are, indeed,
important in the defense against CB4 infections (Vella
and Festenstein, 1992). In addition, IFN-g knockout mice
show a high mortality rate when infected with a dose of
CB4 that is nonlethal to wt mice (Horwitz et al., 1999). Still
unresolved is whether organ-specific NK cell activities
account for our findings with CB4 infection like those
with mCMV infection. Nevertheless, it is clear that NOS2
is indispensable for a fast and efficient clearance of CB4
in the livers of infected mice.
is. (E and F) Day 7 p.i. (E) Liver from a wt mouse and (F) liver from an
d to a normal appearance, whereas livers of infected NOS22/2 mice
going ballooning degeneration. (G) The liver from an NOS22/2 mouse
patitis. The sections shown are representative of 3 to 8 infected andpoptos
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213CB4 INFECTION IN NOS22/2 MICEZaragoza et al. showed that coxsackievirus B3 infec-
tion of young (3 weeks of age) NOS22/2 mice resulted in
severe pancreatitis, whereas wt mice developed only a
inor pancreatitis (Zaragoza et al., 1999). Yet, in our
tudies of adult (8–12 weeks of age) mice, CB4 caused
hronic pancreatitis with extensive damage to the exo-
rine pancreas in both the NOS22/2 and the wt strains.
Thus, NOS2 expression in the pancreata of infected wt
mice (Fig. 1) was not sufficient to prevent the extensive
degranulation and necrosis of acinar tissues.
Others have reported that the regeneration of hepato-
cytes was impaired in NOS22/2 mice after partial hepa-
ectomy (Rai et al., 1998); i.e., those hepatocytes had
educed proliferative activity and an increased tendency
o die by apoptosis. We observed here that the CB4-
nduced viral hepatitis was prolonged in infected
OS22/2 mice compared to wt mice. In parallel, viral
learance was constrained in these mice, although once
he virus had cleared, the livers regained a normal his-
ological appearance. Since we observed histological
igns of mitotic activities in both NOS22/2 and wt mice
during the acute stage as well as the recovery phase
after the CB4-induced hepatitis, possibly the most impor-
tant role for NOS2 during an infection with CB4 is to
restrain viral replication. Indeed, even differences in the
regenerative capacities of hepatocytes between wt and
NOS22/2 mice during CB4 infection did not hinder recov-
ry in the livers of both strains once the infectious virus
s cleared.
CB4 infections have been cited as contributors to
ancreatic b-cell damage and/or to triggering an auto-
mmune process resulting in b-cell death and diabetes
(reviewed in Graves et al., 1997; Hyoty et al., 1998; Knip
and Åkerblom, 1999; Szopa et al., 1993). CB4 can infect
pancreatic b-cells in vivo and in vitro. Moreover, b-cells
express NOS2 in response to proinflammatory cytokines
and dsRNA (Eizirik et al., 1996; Heitmeyer et al., 1999).
Therefore, NOS2 has been proposed an an antiviral
defense mechanism in virally infected b-cells (Eizirik and
eijerstam, 1994). In the present study, we found NOS2
xpressed mainly by cells infiltrating the exocrine re-
ions of infected pancreata from wt mice, whereas few,
f any, islet cells expressed NOS2 (Fig. 1B). Moreover,
ancreatic b-cells were well preserved in the infected
OS22/2 mice (Fig. 3), and no hyperglycemia was de-
tected in either infected wt or NOS22/2 mice at any time
oint during the 8-week observation period. Together,
hese data clearly suggest that NOS2 is not important for
b-cell survival during an infection with CB4.
In accord, Roivainen et al. found that coxsackievirus
5 infection of human pancreatic islets in vitro failed to
induce NOS2 mRNA expression (Roivainen et al., 2000).
Although those and our present findings do not exclude
the possibility that NOS2 can be expressed by b-cells
and play a role in preventing the death of such cells in
the pancreas during infections with other viruses, induc- (tion of NOS2 does not appear to be a common event in
pancreatic b-cells infected with coxsackie B viruses.
The molecular mechanism(s) by which NO restrains
B4 replication remains speculative. Although NO can
nhibit the replication of several RNA and DNA viruses in
itro (Reiss and Komatsu, 1998), little is known about the
ode of action of NO in these systems. Owing to its
apid reaction with other radicals, NO can form potent
eactive nitrogen oxide species (RNOS), and these radi-
als mediate oxidative or nitrosative stress enabling
hem to directly affect numerous molecular targets
Akaike et al., 1998). For example, NO and RNOS can
inhibit the human immunodeficiency virus-1 reverse tran-
scriptase in vitro (Persichini et al., 1999). More relevant to
he present study is the elegant work of Saura et al.
1999), who showed that NO inactivates the protease 3C
f coxsackievirus B3. This was caused by the S-nitrosy-
ation of a critical cysteine residue in the active site of the
nzyme, and the inactivation resulted in cessation of the
iral life cycle. Considering the fundamental similarities
mong coxsackieviral serotypes (Rueckert, 1985), con-
eivably NOS2-derived NO inhibited the replication of
B4 with a similar mechanism. In fact, we have prelim-
nary data showing that the NO-donor SNAP inhibited
B4 replication in HeLa cell cultures (M. Flodstro¨m and
. S. Sarvetnick, unpublished data). However, other
echanisms may also be involved in restraining CB4
eplication and spread, since NO can affect a variety of
ctivities in infected cells, aggravating conditions
nough to halt viral replication (Gross and Wohlin, 1995;
ink and Mitchell, 1998).
In summary, this study proposed that NOS2 is not a
art of an intracellular antiviral defense mechanism that
revents pancreatic b-cell depletion during CB4 infec-
ion. Nevertheless, NOS2 (and NO) is extremely impor-
ant during the early stages of infection when it contrib-
tes to the restriction of viral replication, clearance of
nfectious virus, and host survival. NOS2 does not pre-
ent autodigestion and viral cytolysis of the acinar cells
n the exocrine pancreas, yet promotes the rapid clear-
nce of virus from infected livers and, in turn, hastens
ecovery from CB4-induced hepatitis. Moreover, our re-
ults delineate differences among organs in terms of
tilizing NOS2 to clear infectious CB4. We conclude that
OS2 and NO, rather than having a pathogenic role,
ave a protective function during acute infection with
B4.
MATERIALS AND METHODS
ice
Wt mice (C57BL/6, 129SvEv, and F2(C57BL63129))
ere obtained from The Jackson Laboratory (Bar Harbor,
E). Breeding pairs of homozygous male and female
OS22/2 (F2(C57BL/6J3129SvEv)) mice (MacMicking et
l., 1995) were kindly provided by Drs. J. S. MudgettMerck Research Laboratories, Rahway, NJ), J. D. Mac-
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214 FLODSTRO¨M ET AL.Micking, and C. Nathan (Cornell University Medical Col-
lege, New York, NY) and were bred under specific-patho-
gen-free conditions in the animal facility at The Scripps
Research Institute (La Jolla, CA). All mice were 8–10
weeks of age at the initiation of the experiments, and
experiments were conducted in accordance with institu-
tional guidelines for animal care and use.
Virus and virus titration
Mice were infected with intraperitoneal injections of
coxsackievirus group B type 4 strain E2. Viral stocks,
originally derived from Roger Loria (Medical College of
Virginia, Virginia Commonwealth University, Richmond,
VA), were obtained from Charles Gauntt (University of
Texas, San Antonio, TX). The stock of CB4 (CB4 strain E2)
used for the present study was generated in monolayers
of HeLa cells and titrated as previously described (Hor-
witz et al., 1999). In the study each infected mouse was
given one single injection with 102 or 104 PFU of CB4.
Viral titers in separate organs from infected mice were
quantitated by plaque assays on HeLa cells (American
Type Culture Collection, Rockville, MD). Briefly, organs
were aseptically removed, weighed, and homogenized in
Dulbecco’s modified Eagle medium. After two rounds of
freeze–thawing, virus was titrated by plaque formation on
monolayers of HeLa cells. Each determination was done
in duplicate. Viral titers were quantitated as PFU per
gram of wet tissue and are presented in the text as
log10(PFU/g tissue). The detection limit of the assay is 10
FU/g tissue.
eterminations of blood glucose levels
Glucose levels were measured in blood from the tail
eins using Glucometer Elite strips (Bayer, Pittsburgh, PA).
istology and immunochemistry
Organs from uninfected and infected mice were re-
oved and immediately fixed in 10% formaldehyde.
ieces of the different organs, not larger than 8 3 8 3 8
m, were fixed to obtain an efficient fixation. After being
rocessed for paraffin sectioning, 4-mm-thick sections
ere prepared and stained with hematoxylin/eosin and
n some cases, Massons trichrome. For immunohisto-
hemistry the sections were stained with a primary an-
ibody to insulin (DAKO, Carpinteria, CA), glucagon
DAKO), or NOS2 (Upstate Biotechnology, Lake Placid,
Y). Bound antibody was detected with a secondary
ntibody (biotinylated anti-guinea pig IgG or biotinylated
nti-rat IgG) in conjunction with the Vectastatin ABC
peroxidase) kit (Vector Laboratories, Inc., Carpinteria,
A). Diaminobenzidine (Sigma, St. Louis, MO) was the
hromogen used to detect the staining, and slides were
ounterstained in Mayer’s hematoxylin. Liver morphology
as inspected for evidence of liver injury by a patholo-
ist (Dr. H. Fox, Department of Neuropharmacology, Thecripps Research Institute), who was unaware of the
dentity of the samples.
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